Immune Modulation and Atherosclerosis
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 233
Special Issue Editor
Special Issue Information
Dear Colleagues,
Atherosclerosis is characterised by the build-up of fatty substances, known as plaques or atheroma, within arteries. It is a dominant cause of cardiovascular disease (CVD) and a leading contributor to global mortality rates and global disability. Current therapy and prevention strategies aim to reduce the risk factors associated with CVD, including diabetes, hypertension, smoking, and obesity. Over the last two decades, basic research has revealed the importance of the immune system in the development and progression of CVD. An inflammatory immune response, triggered by factors such as stress, hyperlipidaemia, and infection, is now understood to contribute to complications associated with CVD. In contrast, immuno-regulatory responses can reduce CVD development.
Immune modulatory therapy, therefore, provides a unique opportunity to target the cause of atherosclerosis rather than the associated risk factors. This strategy would enable the protection of a much larger section of society, particularly those living below the poverty line, and achieve a significant reduction in the economic burden of CVD.
Prof. Dr. Xinjie Lu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atherosclerosis
- cardiovascular disease
- immune modulatory therapy
- vaccinations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
